Risultati della ricerca - Dafna D Gladman

Raffina i risultati
  1. 1
    Psoriatic arthritis

    Psoriatic arthritis di Dafna D. Gladman

    Pubblicazione 2009
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Atherosclerosis in psoriatic disease: latest evidence and clinical implications

    Atherosclerosis in psoriatic disease: latest evidence and clinical implications di Lihi Eder, Dafna D. Gladman

    Pubblicazione 2015
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program

    Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program di Dafna D. Gladman, Vimal Chandran

    Pubblicazione 2010
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments

    Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments di Zahi Touma, Dafna D. Gladman

    Pubblicazione 2017
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  5. 5
    Venous syndromes and pulmonary embolism in systemic lupus erythematosus.

    Venous syndromes and pulmonary embolism in systemic lupus erythematosus. di Dafna D. Gladman, Murray B. Urowitz

    Pubblicazione 1980
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Psoriatic arthritis

    Psoriatic arthritis di Vanessa Ocampo D, Dafna D. Gladman

    Pubblicazione 2019
    Testo Testo
    Pré-impressão
    Aggiungi alla lista
    Salvato in:
  7. 7
    Psoriatic spondyloarthropathy: a long term prospective study.

    Psoriatic spondyloarthropathy: a long term prospective study. di John G. Hanly, Michelle Russell, Dafna D. Gladman

    Pubblicazione 1988
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies

    Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies di Konstantinos Tselios, Dafna D. Gladman, Murray B. Urowitz

    Pubblicazione 2016
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  9. 9
    Treatment guidelines in psoriatic arthritis

    Treatment guidelines in psoriatic arthritis di Alexis Ogdie, Laura C. Coates, Dafna D. Gladman

    Pubblicazione 2019
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  10. 10
    Dactylitis in Psoriatic Arthritis: Prevalence and Response to Therapy in the Biologic Era

    Dactylitis in Psoriatic Arthritis: Prevalence and Response to Therapy in the Biologic Era di Dafna D. Gladman, Olga Ziouzina, Arane Thavaneswaran, Vinod Chandran

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Predictors for radiological damage in psoriatic arthritis: results from a single centre

    Predictors for radiological damage in psoriatic arthritis: results from a single centre di Simon Bond, Vernon T. Farewell, Catherine T. Schentag, Dafna D. Gladman

    Pubblicazione 2006
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Excessive paternal transmission in psoriatic arthritis

    Excessive paternal transmission in psoriatic arthritis di Proton Rahman, Dafna D. Gladman, Catherine T. Schentag, Artūras Petronis

    Pubblicazione 1999
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Responses to Adalimumab in Patients with Active Psoriatic Arthritis Who Have Not Adequately Responded to Prior Therapy: Effectiveness and Safety Results From an Open-label Study

    Responses to Adalimumab in Patients with Active Psoriatic Arthritis Who Have Not Adequately Responded to Prior Therapy: Effectiveness and Safety Results From an Open-label Study di Dafna D. Gladman, John S. Sampalis, OLIVIER ILLOUZ, B. Guérette

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis

    Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis di V. Chandran, Sita Bhella, Catherine T. Schentag, Dafna D. Gladman

    Pubblicazione 2007
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Incremental Effects of Comorbidity on Quality of Life in Patients with Psoriatic Arthritis

    Incremental Effects of Comorbidity on Quality of Life in Patients with Psoriatic Arthritis di Janice Husted, Arane Thavaneswaran, Vinod Chandran, Dafna D. Gladman

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50

    Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50 di Zahi Touma, Dafna D. Gladman, Dominique Ibañez, Murray B. Urowitz

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome

    Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome di Amanda Steiman, Dafna D. Gladman, Dominique Ibañez, Murray B. Urowitz

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Psoriatic arthritis assessment tools in clinical trials

    Psoriatic arthritis assessment tools in clinical trials di Philip J. Mease, Christian Antoni, Dafna D. Gladman, W Taylor

    Pubblicazione 2005
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  19. 19
    Is There an Advantage Over SF-36 with a Quality of Life Measure That Is Specific to Systemic Lupus Erythematosus?

    Is There an Advantage Over SF-36 with a Quality of Life Measure That Is Specific to Systemic Lupus Erythematosus? di Zahi Touma, Dafna D. Gladman, Dominique Ibañez, Murray B. Urowitz

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis

    Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis di Vinod Chandran, David Tolusso, Richard J. Cook, Dafna D. Gladman

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: